
Opportunities and Obstacles for Personalized Cancer Vaccines
Drawing on successful breakthroughs with preventive messenger RNA (mRNA) vaccines for infectious diseases such as COVID-19, many innovative vaccine developers are turning their attention to personalized cancer vaccines (1). Although the business models, …